Collateral Global is a UK registered Charity (No. 1195125) dedicated to researching, understanding, and communicating the effectiveness and collateral impacts of the Mandated Non-Pharmaceutical Interventions (MNPIs) taken by governments worldwide in response to the COVID-19 pandemic.
For more information, see our FAQs page.
Why Collateral Global
Utilizing the enduring principles of scientific inquiry, we aim to provide scholarship and research, building an evidence-based understanding of mitigation measures that is both accessible and actionable.
Our Vision, Mission, & Strategy
Our Vision: A world where pandemic policy responses maximise health and well-being for all.
Our Mission: Cultivating a better understanding of the impact of the COVID-19 responses.
Our Strategy: To collate, review, and analyse the evidence; to assess the impact of measures taken across the globe; to communicate with clarity, compassion and objectivity.
Our Contributors
Our contributors come from all over the world and represent a range of lived experiences, professions, and ideologies. Articles can be published anonymously where requested; CG keeps all contributors’ names on a confidential database. In case of anonymised publication, we will only release data to third parties where the contributor has consented.
Get Involved
Visit our Get Involved page to learn more about how you can support Collateral Global’s mission.
Who We Are
Collateral Global is made up of an international and collaborative community of academics, health professionals, and citizens who document, study, and communicate the collateral effects of the measures taken by governments to mitigate the damage of the COVID-19 pandemic.
-
Dr Jennie Bristow
CG Editorial Board Senior Lecturer in Sociology, Canterbury Christ Church University -
Professor Andreas Sönnichsen
CG Editorial Board Professor of Family Medicine at the Center of Public Health, Medical University of Vienna -
Professor Jonathan Ketcham
CG Editorial Board Professor of Economics at the W.P. Carey School’s Department of Economics, Arizona State University -
Professor David Livermore
CG Editorial Board Professor of Medical Microbiology, University of East Anglia
Our Values
Objectivity
The scientific method determines our approach. Theory has to answer to evidence while ensuring the conceptual framework, sources, and methods are declared and clear.
Compassion
Care for people drives us. Disease, suffering, and death are part of the human condition, and we should all support each other to minimise harm. We are not interested in accusation and blame.
Optimism
We have faith and belief in human ingenuity to find better solutions, grasp the nettle, and establish good outcomes grounded in reality.
Get Involved
Support the Collateral Global project by contributing news and research, donating, signing up for our newsletter, or sharing us on social media.